1.2520
+0.0220
+(1.79%)
At close: April 17 at 9:17:15 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
116,590
116,590
76,433
96,631
99,535
Operating Income
-116,590
-116,590
-76,433
-96,631
-99,535
Net Non Operating Interest Income Expense
2,726
2,726
3,714
427
425
Other Income Expense
--
--
--
--
920
Pretax Income
-113,863
-113,863
-72,719
-96,204
-98,189
Tax Provision
55
55
7
70
-381
Net Income Common Stockholders
-113,918
-113,918
-72,726
-96,274
-97,809
Diluted NI Available to Com Stockholders
-113,918
-113,918
-72,726
-96,274
-97,809
Basic EPS
-1.06
-1.17
-0.76
-1.24
-1.78
Diluted EPS
-1.06
-1.17
-0.76
-1.24
-1.78
Basic Average Shares
96,161.1140
97,350.4270
95,121.3900
77,661.2900
54,948.8760
Diluted Average Shares
96,161.1140
97,350.4270
95,121.3900
77,661.2900
54,948.8760
Total Operating Income as Reported
-116,589
-116,589
-76,432
-96,631
-98,614
Total Expenses
116,590
116,590
76,433
96,631
99,535
Net Income from Continuing & Discontinued Operation
-113,918
-113,918
-72,726
-96,274
-97,809
Normalized Income
-113,918
-113,918
-72,726
-96,274
-98,725.4120
Interest Income
2,700
--
--
--
--
Net Interest Income
2,726
2,726
3,714
427
425
EBIT
-116,590
-116,590
-76,433
-96,631
-99,535
EBITDA
-109,045
-109,045
-67,272
-83,469
-86,316
Reconciled Depreciation
-925
-925
-13,998
13,162
8,376
Net Income from Continuing Operation Net Minority Interest
-113,918
-113,918
-72,726
-96,274
-97,809
Total Unusual Items Excluding Goodwill
--
--
--
--
920
Total Unusual Items
--
--
--
--
920
Normalized EBITDA
-109,045
-109,045
-67,272
-83,469
-87,236
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
--
3.5880
12/31/2021 - 4/12/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
MVR0.BE Medivir AB
0.1372
-2.42%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
PROT Proteonomix, Inc.
0.0000
0.00%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
ICY.HA Incyte Corp
51.16
-0.31%
W1H.F Onco-Innovations Limited
1.0200
-2.86%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
MVR0.F Medivir AB (publ)
0.1458
-1.88%